We are live on ! Find out more
DAM

DLD Asset Management Portfolio holdings

AUM $1.51B Turnover 51.11%
1-Year Est. Return 5.32%
This Fund
S&P 500
This Quarter Est. Return
+4.88%
1 Year Est. Return
+5.32%
3 Year Est. Return
+10.27%
5 Year Est. Return
+32.59%
10 Year Est. Return
–
AUM
$2.4B
AUM Growth
-$313M
Cap. Flow
-$740M
Cap. Flow %
-30.79%
Top 10 Hldgs %
65.82%
Holding
131
New
33
Increased
20
Reduced
12
Closed
47
Avg Time Held Equity + Options
0.3 years
Top 10 Avg Time Held Equity + Options
0.2 years
Top 20 Avg Time Held Equity + Options
0.3 years
Avg Time Held Equity only
0.3 years
Top 10 Avg Time Held Equity only
0.4 years
Top 20 Avg Time Held Equity only
0.2 years

Top Buys

Rank Stock Value
1
APC icon
Anadarko Petroleum
APC
+$37.2M
2
STI icon
SunTrust Banks, Inc.
STI
+$28.3M
3
WBC
WABCO HOLDINGS INC.
WBC
+$21M
4
DATA
Tableau Software, Inc.
DATA
+$16.6M
5
BPL
Buckeye Partners, L.P.
BPL
+$15.1M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$82M
2
AMGN icon
Amgen
AMGN
+$50.2M
3
ULTI icon
Ultimate Software Group Inc
ULTI
+$23.1M
4
TFC icon
Truist Financial
TFC
+$22.1M
5
QCOM icon
Qualcomm
QCOM
+$19.5M

Sector Composition

Rank Sector Weight
1 Miscellaneous 76.99%
2 Technology 5.32%
3 Healthcare 4.29%
4 Communication Services 3.47%
5 Industrials 2.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
BKS
51
DELISTED
Barnes & Noble
BKS
$1.67M 0.07%
+250,000
New +$1.36M
2019 Q2
0 quarters
LTXB
52
DELISTED
LegacyTexas Financial Group Inc
LTXB
$1.61M 0.07%
+39,634
New +$1.55M
2019 Q2
0 quarters
ENTX icon
53
Entera Bio
ENTX
$482M
$1.27M 0.05%
369,442
+37,416
+11% +$145K
2018 Q2
4 quarters
FOMX
54
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$1.25M 0.05%
525,000
+225,000
+75% +$672K
2018 Q4
2 quarters
SXC icon
55
SunCoke Energy
SXC
$864M
$1.24M 0.05%
+100,000
New +$824K
2019 Q2
0 quarters
ICPT
56
PUT
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$1.19M 0.05%
15,000
-1,434,900
-99% -$128M
2018 Q2
4 quarters
CZR icon
57
CALL
DELISTED
Caesars Entertainment Corporation
CZR
$1.18M 0.05%
100,000
– –
2019 Q1
1 quarter
WAGE
58
DELISTED
WageWorks, Inc.
WAGE
$1.02M 0.04%
+20,000
New +$946K
2019 Q2
0 quarters
TDS icon
59
Telephone and Data Systems
TDS
$3.92B
$912K 0.04%
30,000
-45,464
-60% -$1.42M
2018 Q4
2 quarters
BMRN icon
60
CALL
BioMarin Pharmaceuticals
BMRN
$10.8B
$900K 0.04%
+10,500
New +$898K
2019 Q2
0 quarters
CXT icon
61
Crane NXT
CXT
$3.12B
$834K 0.03%
+28,790
New +$838K
2019 Q2
0 quarters
APU
62
DELISTED
AmeriGas Partners, L.P.
APU
$496K 0.02%
+14,250
New +$499K
2019 Q2
0 quarters
AMRN icon
63
Amarin Corp
AMRN
$244M
$485K 0.02%
1,250
-2,250
-64% -$824K
2019 Q1
1 quarter
SVRA icon
64
CALL
Savara
SVRA
$974M
$425K 0.02%
+180,000
New +$1.6M
2019 Q2
0 quarters
VSM
65
PUT
DELISTED
Versum Materials, Inc.
VSM
$402K 0.02%
+7,800
New +$403K
2019 Q2
0 quarters
GCVRZ
66
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$335K 0.01%
644,000
– –
2018 Q3
3 quarters
TSS
67
DELISTED
Total System Services, Inc.
TSS
$321K 0.01%
+2,500
New +$275K
2019 Q2
0 quarters
ENTXW icon
68
CALL
DELISTED
Entera Bio Ltd. Warrant
ENTXW
$129K 0.01%
311,923
+1,900
+0.6% +$1.18K
2019 Q1
1 quarter
NVAX icon
69
CALL
Novavax
NVAX
$2.11B
$39K ﹤0.01%
134,000
+85,795
+178% +$675K
2018 Q4
2 quarters
CHK icon
70
CALL
DELISTED
Chesapeake Energy Corporation
CHK
$39K ﹤0.01%
+100
New +$50K
2019 Q2
0 quarters
HSTO
71
CALL
DELISTED
Histogen Inc. Common Stock
HSTO
$3K ﹤0.01%
59
-5,092
-99% -$884K
2018 Q3
3 quarters
ABBV icon
72
PUT
AbbVie
ABBV
$501B
– –
-500,000
Closed -$40.3M –
ALDX icon
73
PUT
Aldeyra Therapeutics
ALDX
$44.5M
– –
-117,300
Closed -$1.06M –
AMD icon
74
PUT
Advanced Micro Devices
AMD
$918B
– –
-100,000
Closed -$2.55M –
AMGN icon
75
Amgen
AMGN
$235B
– –
-280,220
Closed -$50.2M –
1 2
3
4 5

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.51B AUM 33.02% 1-Year Est. Return
SC
Styrax Capital New York $1.52B AUM 57.44% 1-Year Est. Return
HCM
Hodges Capital Management Dallas, Texas $1.51B AUM 85.85% 1-Year Est. Return
NB
NBT Bank Norwich, New York $1.51B AUM 24.9% 1-Year Est. Return
WFA
Wellspring Financial Advisors Cleveland, Ohio $1.52B AUM 29.68% 1-Year Est. Return
RIM
Rush Island Management New York $1.51B AUM 8.12% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.52B AUM 3.09% 1-Year Est. Return

DLD Asset Management's Q2 2019 Portfolio in Review

As of Q2 2019, DLD Asset Management held 131 positions worth $2.4B, down 12% from $2.72B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

DLD Asset Management withdrew a net $740M in Q2 2019, closing 47 positions and reducing 12 holdings. Its most notable exit was Biogen, an estimated $82M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 77% of assets, down from 79% a quarter earlier, followed by Technology and Healthcare.

Against the trend, DLD Asset Management opened a new position in Anadarko Petroleum worth $39.2M.

  • DLD Asset Management's largest Q2 2019 buy was Anadarko Petroleum: 555,200 shares worth $39.2M.
  • DLD Asset Management added most to WABCO HOLDINGS INC. in Q2 2019, an estimated $21M increase.
  • DLD Asset Management's biggest Q2 2019 reduction was Liberty Global Class A, cutting an estimated $3.78M.
  • DLD Asset Management fully exited Biogen in Q2 2019, selling an estimated $82M.
  • DLD Asset Management's ten largest holdings make up 66% of its $2.4B portfolio in Q2 2019.
  • DLD Asset Management opened 33 new positions and closed 47 in Q2 2019.
  • DLD Asset Management's portfolio value fell 12% quarter-over-quarter to $2.4B.

Based on DLD Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.